FIELD: medicine, cosmetology, dermatology. SUBSTANCE: invention relates to curative agent exhibiting beneficial effect on functions of skin cells. Agent comprises combination of lactic acid bacteria cellular wall product obtained by hydrolysis with lysozyme and extracellular water-soluble peptidoglycans excreted by growing lactic acid bacteria in cultural medium as active component influencing on biosynthetic and proliferative activity of skin tissue fibroblasts. Agent normalizes biosynthetic and proliferative activity of skin tissue fibroblasts and it is effective for normal and dry skin care, especially, in symptoms of skin ageing and wilting. EFFECT: enhanced effectiveness and valuable properties of agent. 1 tbl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PREPARATION NORMALIZING THE FUNCTIONS OF CUTANEOUS TISSUE CELLS | 2001 |
|
RU2197225C1 |
| METHOD FOR PREPARING BIOLOGICALLY ACTIVE COMPONENT FOR MAKING SKIN CARE PRODUCT, AND COMPONENT PREPARED BY SUCH METHOD | 2009 |
|
RU2440096C2 |
| COSMETIC PRODUCT IMPROVING PHYSIOLOGICAL STATE OF SKIN | 2002 |
|
RU2221545C1 |
| COSMETIC PRODUCT | 2002 |
|
RU2221547C1 |
| AGENT NORMALIZING METABOLISM IN SKIN TISSUE | 2002 |
|
RU2229886C1 |
| METHOD FOR PRODUCTION OF GLYCOPEPTIDE AND GLYCOPEPTIDE PRODUCT FOR MEDICINE APPLICATION OBTAINED THEREBY | 2005 |
|
RU2304167C2 |
| RECOMBINANT PLASMID DNA DETERMINING SYNTHESIS OF HUMAN FIBROBLAST INTERFERON IN YEAST CELLS, METHOD OF ITS CONSTRUCTION AND YEAST STRAIN SACCHAROMYCES CEREVISIAE AS PRODUCER OF HUMAN FIBROBLAST INTERFERON | 1998 |
|
RU2180003C2 |
| METHOD FOR PREPARING COLLAGEN FOR TREATMENT OF PATHOLOGY OF BODY TISSUES | 2002 |
|
RU2214827C1 |
| METHOD FOR CORRECTION OF AGE-SPECIFIC AND PATHOLOGICAL HUMAN SKIN CHANGES | 2007 |
|
RU2373941C2 |
| METHOD OF TREATING COSMETIC SKIN DEFECTS | 2024 |
|
RU2831472C1 |
